Alignment Healthcare Inc. (ALHC) Prices 27.2M Share IPO at $18/Sh
Get Alerts ALHC Hot Sheet
Join SI Premium – FREE
Alignment Healthcare, Inc. (NASDAQ: ALHC), a mission-based, tech-enabled Medicare Advantage company, today announced the pricing of its initial public offering of 27,200,000 shares of its common stock at $18.00 per share, including 5,500,000 shares of common stock to be sold by certain existing stockholders. As part of the offering, existing stockholders have granted to the underwriters a 30-day option to purchase up to an additional 4,080,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on March 26, 2021 under the symbol “ALHC,” and the offering is expected to close on March 30, 2021, subject to customary closing conditions.
The Company intends to use the proceeds of the offering for working capital and general corporate purposes, including continued investments in the growth of its business, and strengthening its balance sheet by potentially repaying debt.
Goldman Sachs & Co. LLC, Morgan Stanley, J.P. Morgan, BofA Securities and William Blair are acting as joint lead book-running managers for the proposed offering. UBS Investment Bank, Piper Sandler and Raymond James are acting as joint book-running managers for the proposed offering.
A registration statement relating to this offering was declared effective by the Securities and Exchange Commission on March 25, 2021.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
- Tailored Brands files for IPO, plans Nasdaq listing under MENW
- Samos Energy raises $230M in NYSE IPO for energy acquisitions
Create E-mail Alert Related Categories
Corporate News, Equity Offerings, IPOsRelated Entities
UBS, William Blair, JPMorgan, Goldman Sachs, Raymond James, Morgan Stanley, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share